DGX vs NRIM · P/E 22, rev $5.94B vs P/E 13, rev $123.7M
Quest Diagnostics Incorporated (DGX) versus Northrim BanCorp Inc (NRIM) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Northrim BanCorp Inc (NRIM) is a banks - regional company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported NRIM revenue for 2026-06-30 was $123.7M. Net income was $29.0M. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
Not investment advice. Open the DGX and NRIM stock pages for the full models.
Not investment advice.